Skip to main content
CVSACovista Inc.Sell5.0·$124.06
CVSA · Decision

Should you buy Covista (CVSA)?

Updated

Covista screens attractively valued at a forward P/E of 13.2 times and a PEG of 0.88, underpinned by four consecutive earnings beats averaging more than 11% above consensus; the chief offset is negative price momentum that has not cleared the minimum threshold, keeping the entry setup cautious despite sound fundamentals.

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Verdict
SELL
Score
5.0/10
Price
$124.06
Entry / Take Profit (TP) / Stop Loss (SL)
/ $132.81 / $116.01

Engine methodology range

Range computation requires sufficient peer-comparable data; available for tickers with peer_count ≥3.

What the engine is tracking

Price momentum has stalled well below the acceptable threshold, with falling on-balance volume indicating distribution rather than accumulation — a near-term headwind that limits the attractiveness of the current entry even as fundamentals remain intact.

Stable
Warnings
Expectation
Over 12 months the stock recovers toward its near-term price target as momentum improves, validating that the weakness was temporary.

CounterThe stock remains above its 200-day moving average, meaning the weakness may be a pullback within a longer uptrend rather than a structural reversal.

At a forward P/E of 13.2 times and a PEG of 0.88, the stock screens as attractively valued, offering a meaningful margin of safety and potential for multiple expansion if earnings momentum continues.

Stable
Valuation breakdown
Expectation
Forward P/E holds at or below 15 times as earnings grow into the valuation, and the stock outperforms sector peers on a 12-month total-return basis.

CounterWeak organic growth limits the catalyst for re-rating; inexpensive stocks with minimal top-line momentum can remain cheap for extended periods.

A Piotroski F-Score of 7 out of 9 combined with strong free-cash-flow quality signals a financially healthy business with limited near-term distress risk.

Stable
Quality breakdown
Expectation
The Piotroski F-Score remains at 7 or above for four consecutive quarters and free-cash-flow quality does not deteriorate materially.

CounterA mid-range moat score means financial strength has not translated into durable pricing power; the quality profile is solid but not exceptional.

▸ Show 1 more pillar

The company has beaten consensus EPS estimates in each of the last four reported quarters, with average upside of roughly 11% above expectations — a pattern consistent with management consistently under-promising and over-delivering.

Stable
Earnings
Expectation
Average quarterly EPS surprise remains above 5% and the beat streak extends to six or more consecutive quarters over the next 12 months.

CounterRevenue growth is near the bottom of the peer range, suggesting beats reflect modest consensus targets on a slow-growth business rather than genuine earnings acceleration.

→ Full pillar scorecard with all 4 pillars + per-dimension breakdown

When this thesis breaks

Falsifiable conditions per pillar — any one trip warrants review independent of price action. Engine-derived; not personalized advice.

Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.

  • P1The company has beaten consensus EPS estimates in each of the last four reported quarters, with average upside of roughly 11% above expectations — a pattern consistent with management consistently under-promising and over-delivering.

    Trip ifEPS surprise falls below 0% for 2 consecutive quarters.

  • P2At a forward P/E of 13.2 times and a PEG of 0.88, the stock screens as attractively valued, offering a meaningful margin of safety and potential for multiple expansion if earnings momentum continues.

    Trip ifForward P/E expands above 20x from the current 13.2x for 2 consecutive quarters.

  • P3A Piotroski F-Score of 7 out of 9 combined with strong free-cash-flow quality signals a financially healthy business with limited near-term distress risk.

    Trip ifPiotroski F-Score falls below 5 out of 9 in any single quarter.

  • P4Price momentum has stalled well below the acceptable threshold, with falling on-balance volume indicating distribution rather than accumulation — a near-term headwind that limits the attractiveness of the current entry even as fundamentals remain intact.

    Trip ifPrice closes above $132.81 (near-term price target) and holds for 2 consecutive weeks, confirming the momentum headwind has resolved.

How the engine reached this verdict

1. Direct answer

TrendMatrix's engine output for Covista Inc. (CVSA) is SELL_IF_HOLDING with medium conviction, score 5.0/10 at $124.06. The F-path SELL output reflects an overall score of 5.0 below the 5.6 soft trigger — multiple weakening dimensions accumulated rather than a single hard-floor breach. Asymmetry R:R of 0.92 is supplementary context, not the trigger.

2. What would change the verdict

The dominant failed gate is reward-to-risk at 0.9 vs threshold 1.5. SELL flips back toward HOLD if reward-to-risk recovers above its threshold AND a co-failing gate also clears. The strongest-cleared gate today is MOMENTUM:4.7>=4.5.

3. What the engine sees

On the bull side: Strong earnings beat streak (4/4); Attractive valuation. On the bear side: Thin upside margin: 6.8%; Weak overall score: 5.0/10; Weak growth. Active engine warnings: V9 Gate Failed: ASYMMETRY:0.9<1.5@spot.

4. Entry, target, and stop

The engine's exit framework anchors to a tactical sell band near $124.06, with structural invalidation at $116.01. The asymmetric R:R against a reversal hypothesis is 1.01 — the upside scenario exists, but it requires multiple structural gates to flip; the downside scenario requires only one more disappointment. The engine's sizing output: 0.5% of portfolio at this asymmetry level (none-conviction tier).

For the full 10-dimension breakdown + V9 gate detail: Why TrendMatrix rates CVSA — 10-dimension breakdown →

Bull case

  • Strong earnings beat streak (4/4)
  • Attractive valuation

Bear case

  • Thin upside margin: 6.8%
  • Weak overall score: 5.0/10
  • Weak growth
Home Stocks CVSA Buy or sell?